Atyr Pharma Inc (ATYR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,154 | -33,777 | -25,216 | -17,547 | -7,155 |
| Depreciation Amortization | 535 | 1,670 | 1,127 | 761 | 348 |
| Other Working Capital | 1,172 | -2,588 | -2,100 | 2,509 | 620 |
| Other Operating Activity | 328 | 1,620 | 1,200 | 758 | 360 |
| Operating Cash Flow | $-10,119 | $-33,075 | $-24,989 | $-13,519 | $-5,827 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 14,500 | -91,424 | -42,044 | -27,256 | -23,378 |
| PPE Investments | 126 | -142 | -174 | -113 | -17 |
| Investing Cash Flow | $14,626 | $-91,566 | $-42,218 | $-27,369 | $-23,395 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,481 | 110,025 | 109,997 | 15,242 | 24,857 |
| Other Financing Activity | 0 | 0 | 0 | 10,886 | 0 |
| Financing Cash Flow | $1,481 | $110,025 | $109,997 | $26,128 | $24,857 |
| Beginning Cash Position | 2,336 | 16,952 | 16,952 | 16,952 | 16,952 |
| End Cash Position | 8,324 | 2,336 | 59,742 | 2,192 | 12,587 |
| Net Cash Flow | $5,988 | $-14,616 | $42,790 | $-14,760 | $-4,365 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,119 | -33,075 | -24,989 | -13,519 | -5,827 |
| Capital Expenditure | -43 | -192 | -174 | -113 | -17 |
| Free Cash Flow | -10,162 | -33,267 | -25,163 | -13,632 | -5,844 |